MicroRNA-122 and cytokeratin-18 have potential as a biomarkers of drug-induced liver injury in European and African patients on treatment for mycobacterial infection

Sarah AE Rupprechter, Derek J Sloan, Wilna Oosthuyzen, Till T Bachmann, Adam T Hill, Kevin Dhaliwal, Kate Templeton, Joshua Matovu, Christine Sekaggya-Wiltshire, James W Dear

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalBritish Journal of Clinical Pharmacology
Early online date11 Jan 2021
Publication statusE-pub ahead of print - 11 Jan 2021

Cite this